Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work
A new British startup believes that artificial intelligence is the key to speedrunning the slow and temperamental process of drug design. Potential Sciences plans to build large-scale chemical datasets by using basic principles of physics to simulate interactions between atoms, then small molecules, then complex amino acids and proteins. With that data, it’s betting it…